These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19821574)

  • 1. Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
    Jones M; Inkielewicz I; Medina C; Santos-Martinez MJ; Radomski A; Radomski MW; Lally MN; Moriarty LM; Gaynor J; Carolan CG; Khan D; O'Byrne P; Harmon S; Holland V; Clancy JM; Gilmer JF
    J Med Chem; 2009 Nov; 52(21):6588-98. PubMed ID: 19821574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
    Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
    J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a "true" aspirin prodrug.
    Moriarty LM; Lally MN; Carolan CG; Jones M; Clancy JM; Gilmer JF
    J Med Chem; 2008 Dec; 51(24):7991-9. PubMed ID: 19049433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets.
    Harmon S; Inkielewicz-Stepniak I; Jones M; Ledwidge M; Santos-Martinez MJ; Medina C; Radomski MW; Gilmer JF
    J Pharm Pharmacol; 2012 Jan; 64(1):77-89. PubMed ID: 22150675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin.
    Cena C; Lolli ML; Lazzarato L; Guaita E; Morini G; Coruzzi G; McElroy SP; Megson IL; Fruttero R; Gasco A
    J Med Chem; 2003 Feb; 46(5):747-54. PubMed ID: 12593655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez C; Praveen Rao PN; Knaus EE
    J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinate.
    Gilmer JF; Moriarty LM; Lally MN; Clancy JM
    Eur J Pharm Sci; 2002 Sep; 16(4-5):297-304. PubMed ID: 12208460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nitrate-substituted pseudocholine esters of aspirin as potential nitro-aspirins.
    Gilmer JF; Moriarty LM; Clancy JM
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3217-20. PubMed ID: 17376682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single oral dose study of two isosorbide-based aspirin prodrugs in the dog.
    Gilmer JF; Murphy MA; Shannon JA; Breen CG; Ryder SA; Clancy JM
    J Pharm Pharmacol; 2003 Oct; 55(10):1351-7. PubMed ID: 14607016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor.
    Carolan CG; Dillon GP; Khan D; Ryder SA; Gaynor JM; Reidy S; Marquez JF; Jones M; Holland V; Gilmer JF
    J Med Chem; 2010 Feb; 53(3):1190-9. PubMed ID: 20067290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
    Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New nitric oxide or hydrogen sulfide releasing aspirins.
    Lazzarato L; Chegaev K; Marini E; Rolando B; Borretto E; Guglielmo S; Joseph S; Di Stilo A; Fruttero R; Gasco A
    J Med Chem; 2011 Aug; 54(15):5478-84. PubMed ID: 21688846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
    Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
    Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide release is not required to decrease the ulcerogenic profile of nonsteroidal anti-inflammatory drugs.
    Jain S; Tran S; El Gendy MA; Kashfi K; Jurasz P; Velázquez-Martínez CA
    J Med Chem; 2012 Jan; 55(2):688-96. PubMed ID: 22148253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, hydrolysis kinetics and anti-platelet effects of isosorbide mononitrate derivatives of aspirin.
    Gilmer JF; Moriarty LM; McCafferty DF; Clancy JM
    Eur J Pharm Sci; 2001 Oct; 14(3):221-7. PubMed ID: 11576827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
    Chowdhury MA; Abdellatif KR; Dong Y; Yu G; Huang Z; Rahman M; Das D; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1324-9. PubMed ID: 20097072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE
    J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P; Momi S
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.